➤ Delhi

i. Applications made by the Company for the premises situated at Plot No. 2, Pocket H, Sector - 5, DSIIDC, Bawana Industrial Area, New Delhi, Delhi (India) – 110039.

a. The Company has filed an application (Form MD-3) dated August 29, 2025 bearing transaction id 252414659514 for Grant of Licence to Manufacture for Sale and Distribution of Class A or Class B medical device which are as under:

(i) Viral DNA Extraction Kit (Spin Column) (Brand Name: Q-Line® Molecular Viral DNA Extraction Kit (Spin Column))

(ii) Viral DNA Extraction Kit (Magnetic Bead) (Q-Line® Molecular Viral DNA Extraction Kit (Magnetic Bead))

(iii) Viral RNA Extraction Kit (Spin Column) (Brand Name: Q-Line® Molecular Viral RNA Extraction Kit (Spin Column))

(iv) Viral RNA Extraction Kit (Magnetic Bead) (Q-Line® Molecular Viral RNA Extraction Kit (Magnetic Bead))

(v) Viral Nucleic Acid Extraction Kit (Spin Column)

(vi) Viral Nucleic Acid Extraction Kit (Magnetic Bead)

(vii) Bacterial Genomic DNA Extraction Kit (Spin Column)

(viii) Bacterial Genomic DNA Extraction Kit (Magnetic Bead)

(ix) Viral Transport Medium (VTM)

(x) Multi Con Level 1 (MCL-1)

(xi) Multi Con Level 2 (MCL-2)

(xii) Multi Calibrator (MCAL)

(xiii) 13. Typhoid IgM/IgG Antibody Test

(xiv) Chikungunya IgM/IgG Antibody Test

(xv) Filariasis IgM/IgG Antibody Test

(xvi) H. Pylori IgM/IgG Antibody Test

(xvii) Rickettsia IgM/IgG Antibody Test

(xviii) 18. Toxoplasma IgM/IgG Antibody Test

b. The Company has filed an application (Form MD-3) dated July 23, 2025 bearing transaction id 7871017839739/8426217639446 for Grant of Licence to Manufacture for Sale and Distribution of Class A or Class B medical device which are as under:

(i) CLIA Triiodothyronine (TT3)

(ii) CLIA Thyroxine (TT4)

(iii) CLIA Thyroid-Stimulating Hormone (TSH)

(iv) CLIA Free Triiodothyronine (FT3)

(v) CLIA Free Thyroxine (FT4)

(vi) CLIA Luteinizing Hormone (LH)

(vii) CLIA Follicle-Stimulating Hormone (FSH)

(viii) CLIA Beta Human Chorionic Gonadotropin (β-HCG)

(ix) CLIA Vitamin D

(x) CLIA Folate

(xi) CLIA Immunoglobulin E (IgE)

(xii) CLIA Ferritin (FER)

(xiii) CLIA Insulin

(xiv) CLIA Prolactin (PRL)

(xv) CLIA Vitamin B12

(xvi) CLIA Anti-Mullerian Hormone (AMH)

(xvii) IFA Cystatin C (CysC) Test Kit

(xviii) IFA Microalbumin (mAlb) Test Kit

(xix) IFA NGAL (Neutrophils Gelatinase Associated Lipocalin) Test Kit

(xx) IFA HbA1c Test Kit

(xxi) IFA TSH (Thyroid Stimulating Hormone) Test Kit

(xxii) IFA T3 (Triiodothyronine) Test Kit

(xxiii) IFA T4 (Thyroxine) Test Kit

(xxiv) IFA 25-OH-VD Test Kit

(xxv) IFA β-HCG Test Kit

c. The Company has filed an application (Form MD-3) dated August 06, 2025 transaction id 2237019730617 for Grant of Licence to Manufacture for Sale and Distribution of Class A or Class B medical device which are as under:

(i) AB Standard

(ii) Electrolyte Control Solution Set (LNH)

(iii) Electrolyte Cleaning Solution